Related Experiment Video
Updated: Jan 2, 2026

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.1K
Progress Toward Regional Measles Elimination - Worldwide, 2000-2018
MMWR. Morbidity and Mortality Weekly Report
|December 6, 2019
Summary
Global measles vaccination efforts have saved millions of lives, but recent increases in cases and deaths highlight the need for stronger immunization systems and surveillance to achieve elimination goals.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- World Health Assembly set measles control milestones for 2015 and endorsed the Global Vaccine Action Plan for regional elimination by 2020.
- Progress in measles control and elimination efforts has been tracked globally since 2000.
Purpose of the Study:
- To update the progress report on World Health Assembly milestones and regional measles elimination targets for the period 2000-2018.
- To assess the impact of measles vaccination on mortality and identify challenges to achieving elimination.
Main Methods:
- Analysis of global data on measles vaccination coverage (MCV1), incidence, and mortality from 2000 to 2018.
- Estimation of measles deaths averted by vaccination during the study period.
Main Results:
- Estimated first dose measles-containing vaccine (MCV1) coverage increased from 72% to 86% globally between 2000 and 2018.
- Global annual measles incidence decreased by 66% and estimated deaths by 73% during 2000-2018, with vaccination averting 23.2 million deaths.
- However, measles cases rose by 167% in 2018 compared to 2016, and mortality increased since 2017.
Conclusions:
- Sustained progress towards measles elimination requires strengthened routine immunization systems, addressing immunity gaps, and enhanced surveillance.
- Achieving measles elimination necessitates coordinated global efforts to reach at least 95% coverage with two doses of measles vaccine.
Related Concept Videos
Vaccinations
51.0K
Overview
51.0K
Principles of Disease Surveillance
423
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
423
Microorganisms in Medicine and Therapeutics
886
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
886
Prevalence and Incidence
1.4K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K
Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K

